Susquehanna Fundamental Investments’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,400
| Closed | -$301K | – | 899 |
|
|
2023
Q1 | $301K | Sell |
8,400
-20,263
| -71% | -$725K | 0.01% | 785 |
|
|
2022
Q4 | $1.13M | Sell |
28,663
-4,518
| -14% | -$178K | 0.02% | 622 |
|
|
2022
Q3 | $1.2M | Buy |
+33,181
| New | +$1.2M | 0.02% | 748 |
|
|
2022
Q1 | $1.4M | Buy |
45,647
+24,781
| +119% | +$757K | 0.03% | 708 |
|
|
2021
Q4 | $652K | Hold |
20,866
| – | – | 0.02% | 815 |
|
|
2021
Q3 | $319K | Buy |
+20,866
| New | +$319K | 0.01% | 1384 |
|